Amarin Competitors
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|---|
LLY | Eli Lilly and | Outperform |
16
|
$770.00 | Buy/Sell | $636.99 | 13.96% | 9 | $693.31B |
JNJ | Johnson & Johnson | Outperform |
9
|
$154.64 | Buy/Sell | $174.55 | 9.93% | 3 | $372.17B |
AZN | AstraZeneca PLC | Outperform |
17
|
£121.10 | Buy/Sell | £165.99 | 34.64% | 16 | £187.73B |
AMGN | Amgen | Outperform |
4
|
$312.47 | Buy/Sell | $303.65 | 2.41% | 8 | $167.62B |
PFE | Pfizer | Outperform |
2
|
$28.64 | Buy/Sell | $32.87 | 6.49% | 6 | $162.29B |
SAN | Sanofi | Outperform |
16
|
89.17€ | Buy/Sell | 102.80€ | 22.80% | 9 | 111.47€B |
BMY | Bristol-Myers Squibb | Hold |
2
|
$44.03 | Buy/Sell | $58.15 | 22.64% | 10 | $89.25B |
GILD | Gilead Sciences Inc | Outperform |
11
|
$67.72 | Buy/Sell | $87.82 | 18.13% | 14 | $84.36B |
BAYN | Bayer | Hold |
5
|
28.58€ | Buy/Sell | 45.15€ | 4.97% | 4 | 28.08€B |
MTNB | Matinas BioPharma Holdings | Buy |
7
|
$0.17 | Buy/Sell | $0.65 | 488.24% | 0 | $44.04M |
CDXI | Cardax | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% | 0 | $0.00M |